Q4 2023 Axsome Therapeutics Inc Earnings Call Transcript
Hello, and welcome to the Axsome Therapeutics Fourth Quarter and Full Year 2023 Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to turn the call over to Chief Operating Officer, Mark Jacobson. Please go ahead, sir.
Good morning and thank you all for joining us on today's conference call. This morning we issued our earnings press release, providing a corporate update and details of the company's financial results for the fourth quarter and full year of 2023.
The release crossed the wire a short time ago and is available on our website at axsome.com. During today's call, we will be making certain forward-looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents.
Our clinical and nonclinical plans, our plans to present or report additional data, the anticipated conduct and the source of future
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |